Santisteban, M., Pérez Solans, B., Hato, L., Sánchez Bayona, R., Idoate Gastearena, M. Á., & Inogés, S. (2021). Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: Clinical and translational analysis.
Citación estilo ChicagoSantisteban, Marta, Belén Pérez Solans, Laura Hato, Rodrigo Sánchez Bayona, Miguel Ángel Idoate Gastearena, y Susana Inogés. Final Results Regarding the Addition of Dendritic Cell Vaccines to Neoadjuvant Chemotherapy in Early HER2-negative Breast Cancer Patients: Clinical and Translational Analysis. 2021.
Cita MLASantisteban, Marta, et al. Final Results Regarding the Addition of Dendritic Cell Vaccines to Neoadjuvant Chemotherapy in Early HER2-negative Breast Cancer Patients: Clinical and Translational Analysis. 2021.